13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-06-05 Event — SEC 0000315066-26-001419 →

FMR LLC ODYSSEY THERAPEUTICS INC ODTX

Stake: Shares: Class: COMMON STOCK

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
78 transactions
19 buys · 3 sales · 4 awards/exercises
Issuer Cluster
5 13D/G filings on this issuer
4 other filings besides this one
Filer Track Record
41 filings by this filer
40 other filings in the data moat
Short Interest · settle 2026-08-31
DTC 12.81
2,208,908 shares short · -1.8% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-05-11 TPG GP A, LLC J 423,111
2026-05-11 SR ONE CAPITAL MANAGEMENT, LLC 10%+ owner C 474,048
2026-05-11 Li Nan (LN) director C 1,709,543
2026-05-11 Chu Shelley director Buy 11,111 $18.00 $200K
2026-05-11 Glick Gary D director, officer C 27,386
2026-05-11 Opipari Anthony W. officer C 6,965
2026-05-11 Opipari Anthony W. officer Option exercise 541
2026-05-11 Opipari Anthony W. officer F 4 $18.00 $72
2026-05-11 Opipari Anthony W. officer C 18,531
2026-05-11 Opipari Anthony W. officer C 11,083
2026-05-11 Opipari Anthony W. officer C 20,000
2026-05-11 Opipari Anthony W. officer C 17,545
2026-05-11 Opipari Anthony W. officer Option exercise 5,263 $0.10 $526
2026-05-11 Glick Gary D director, officer C 100,000
2026-05-11 Glick Gary D director, officer C 166,116
2026-05-11 Li Nan (LN) director Buy 1,111,111 $18.00 $20.00M
2026-05-11 Li Nan (LN) director C 16,611,626
2026-05-11 LEIDEN JEFFREY M director C 28,698
2026-05-11 LEIDEN JEFFREY M director Option exercise 2,963
2026-05-11 LEIDEN JEFFREY M director F 17 $18.00 $306
2026-05-11 LEIDEN JEFFREY M director C 79,166
2026-05-11 LEIDEN JEFFREY M director C 100,000
2026-05-11 LEIDEN JEFFREY M director C 96,002
2026-05-11 LEIDEN JEFFREY M director Option exercise 28,800 $0.10 $3K
2026-05-11 SR ONE CAPITAL MANAGEMENT, LLC 10%+ owner C 139,366
Showing 25 of 78

Other 13D/G Filings on ODYSSEY THERAPEUTICS INC

FiledFormFilerStakeShares
2026-05-18 SCHEDULE 13D TPG GP A, LLC 7.80% 3,690,146 view →
2026-05-18 SCHEDULE 13D SR ONE CAPITAL MANAGEMENT, LLC 8.00% 3,794,883 view →
2026-05-15 SCHEDULE 13D Dimension Capital II, L.P. 7.10% 3,333,516 view →
2026-05-15 SCHEDULE 13D Jeito II S.L.P. 7.80% 3,690,145 view →

Other Filings by FMR LLC

FiledFormIssuerStakeShares
2026-09-08 SCHEDULE 13G ADI GLOBAL DISTRIBUTION INC view →
2026-09-08 SCHEDULE 13G ONTERRIS INC view →
2026-09-08 SCHEDULE 13G AVANTIS RESPONSIBLE INTERNATIONAL EQUITY ETF view →
2026-08-19 SCHEDULE 13D/A Fidelity Multi-Strategy Credit Fund 52.20% 3,082,424.46 view →
2026-08-06 SCHEDULE 13G AMPLITUDE INC view →
2026-08-06 SCHEDULE 13G ALCOA CORP view →
2026-08-06 SCHEDULE 13G ADEIA INC view →
2026-08-06 SCHEDULE 13G AMERICAN PUBLIC EDUCATION INC view →
2026-08-06 SCHEDULE 13G ACI WORLDWIDE INC view →
2026-08-06 SCHEDULE 13G ALUMIS INC view →
2026-08-06 SCHEDULE 13G ABERCROMBIE & FITCH CO view →
2026-08-06 SCHEDULE 13G ALIGN TECHNOLOGY INC view →
2026-08-06 SCHEDULE 13G BROWN & BROWN INC view →
2026-08-06 SCHEDULE 13G AXOS FINL INC view →
2026-08-06 SCHEDULE 13G ANTERIS TECHNOLOGIES GLOBAL CORP view →
2026-08-04 SCHEDULE 13D/A Fidelity Multi-Strategy Credit Fund 3,070,730.63 view →
2026-07-29 SCHEDULE 13D Fidelity Core Real Estate Fund 8.60% 3,171,441.59 view →
2026-07-08 SCHEDULE 13G CLIMB BIO INC CLYM view →
2026-07-08 SCHEDULE 13G SOUTH BOW CORP SOBO view →
2026-07-08 SCHEDULE 13G TENAX THERAPEUTICS INC TENX view →
Showing 20 of 40

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →